Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Conditions:   Hodgkin Lymphoma;   Lymphoid Leukemia;   Multiple Myeloma;   Myeloid Leukemia;   Monocytic Leukemia;   Non Hodgkin Lymphoma;   Myelodysplasia Intervention:   Drug: Intravenous (IV) and oral Vitamin C Sponsor:   Virginia Commonwealth University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials